98%
921
2 minutes
20
Objective: It was to assess changes in structural parameters in early diabetic retinopathy (DR).
Materials And Methodologies: This study is a retrospective analysis that included patients with early DR admitted to the Affiliated Third Hospital of Nantong University from January 2024 to December 2024. The participants were divided into the non-DR group (NDR group) and the non-proliferative DR group (NPDR group, which included mild, moderate, and severe subgroups) using swept-source optical coherence tomography angiography (SS-OCTA) technology. One-way analysis of variance (ANOVA) and the Kruskal-Wallis test were used to compare parameter differences among the groups.
Results: A total of 208 diabetic patients were included (55 in the NDR group, 153 in the NPDR group) and 51 healthy controls. The results showed that the FAZ area in the NPDR group was significantly larger than that in the control group (CG) (mean difference: +0.38 ± 0.10 mm2, 95% CI [0.25-0.51], P < 0.001), and it was positively correlated with disease severity (trend test P < 0.001). Relative to the CG, NDR group and various stages of NPDR group exhibited greatly lower values in choroidal vascular index (CVI), peripapillary vascular density (ppVD), peripapillary retinal nerve fiber layer thickness (pRNFL), vascular density (VD) in both the superficial and deep retinal vascular complexes, total perfusion area (PA), small vessel density (SVD), disc area, vascular density (FD300) within a 300 µm radius of the foveal center, and capillary plexus blood flow density (P<0.05). NPDR group showed progressively lower values than NDR group, with severity increasing as the condition worsened (P<0.05).
Conclusion: SS-OCTA can effectively monitor changes in structural parameters and serves as a valuable tool for evaluating the progression of early DR.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12316237 | PMC |
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0327770 | PLOS |
Ophthalmol Sci
July 2025
Department of Ophthalmology, Shinshu University School of Medicine, Matsumoto, Nagano, Japan.
Purpose: This study evaluates retinal volume in the macula and peripheral retina in patients with nonproliferative diabetic retinopathy (NPDR), with and without diabetic macular edema (DME), using widefield swept-source OCT (SS-OCT).
Design: Retrospective observational study.
Participants: A total of 98 eyes were included: 30 from patients with NPDR without DME (DME-), 38 from patients with NPDR with DME (DME+), and 30 from age- and sex-matched healthy controls.
Clin Ophthalmol
August 2025
Center for Eye Research and Innovative Diagnostics, Department of Ophthalmology, Oslo University Hospital and Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
Purpose: This study aimed to investigate the metabolic alterations in the vitreous humor of patients with diabetes across different stages of diabetic retinopathy (DR) and explore potential dietary interventions to mitigate these changes.
Patients And Methods: Vitreous samples were collected from 23 patients undergoing vitrectomy and grouped into controls, diabetic without DR, non-proliferative DR (NPDR), and proliferative DR (PDR). Metabolomic analysis was performed using mass spectrometry, focusing on identifying significantly altered metabolites.
BMC Ophthalmol
September 2025
The Fred Hollows Foundation, Sydney, Australia.
Background: Diabetes is an emerging public health problem in low- and middle-income countries. Diabetic Retinopathy (DR) is one of the leading causes of blindness in Nepal. Blindness due to DR can be avoided with timely treatment and regular follow up.
View Article and Find Full Text PDFTransl Vis Sci Technol
August 2025
University of California, San Francisco, Department of Ophthalmology, San Francisco, CA, USA.
Purpose: To compare inflammatory protein levels in the plasma of men and women with nonproliferative diabetic retinopathy (NPDR).
Methods: We recruited 74 NPDR patients (38 men, 36 women), 82 diabetic patients without retinopathy, and 20 patients without diabetes. Patients with intravitreal injections in the past four weeks, ocular comorbidities, active infection, or systemic vasculitis were excluded.
Ocul Immunol Inflamm
August 2025
Department of Ophthalmology, Harvey and Bernice Jones Eye Institute, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Purpose: To evaluate the association between type 2 diabetes mellitus (T2DM) and type 1 diabetes mellitus (T1DM) with the incidence of uveitis.
Methods: This was a retrospective cohort study utilizing the TriNetX Global Collaborative Network. Anonymized participants were patients diagnosed with T2DM or T1DM, including both insulin users and non-insulin users among those with T2DM, with and without diabetic retinopathy (DR).